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Background: Podoconiosis is a non-infectious geochemical lymphoedema of the lower legs associated with a
significant burden of morbidity. There are historical reports of podoconiosis in India, but its current endemicity
status is uncertain. In this investigation we aimed to prioritise the selection of districts for pilot mapping of
podoconiosis in India.
Methods: Through a consultative workshop bringing together expert opinion on podoconiosis with public health
and NTDs in India, we developed a framework for the prioritisation of pilot areas. The four criteria for prioritisation
were predicted environmental suitability for podoconiosis, higher relative poverty, occurrence of lymphoedema
cases detected by the state health authorities and absence of morbidity management and disability prevention
(MMDP) services provided by the National Programme for Elimination of Lymphatic Filariasis.
Results: Environmental suitability for podoconiosis in India was predicted to be widespread, particularly in the
mountainous east and hilly southwest of the country. Most of the districts with higher levels of poverty were in
the central east and central west. Of 286 districts delineated by state representatives, lymphoedemawas known
to the health system in 189 districts and not recorded in 80. Information on MMDP services was unavailable for
many districts, but 169 were known not to provide such services. We identified 35 districts across the country as
high priority for mapping based on these criteria.
Conclusions: Our results indicate widespread presence of conditions associated with podoconiosis in India,
including areas with known lymphoedema cases and without MMDP services. This work is intended to support
a rational approach to surveying for an unrecognised, geographically focal, chronic disease in India, with a view
to scaling up to inform a national strategy if required.
Keywords: ecological niche modelling, evidence consensus, lymphedema, morbidity management and disability prevention,
Podoconiosis, surveillance data, targeting surveys
Introduction
Podoconiosis is a non-infectious geochemical lymphoedema of
the lower legs, caused by long-term barefoot exposure to red
clay soil of volcanic origin.1,2 The disease is associated with spe-
cific environmental and climatic factors and with cultural and
behavioural practices that increase the risk of contact with irri-
tant soils.1 The disease can be prevented by the use of footwear
and the resulting lymphoedema is reversible in its early stages,
while advanced lymphoedema can be managed to reduce the
incidence of painful episodes of acute inflammatory attacks and
prevent or slow progression.3,4 As such, there is a strong ratio-
nale for estimating the burden of disease and identifying popula-
tions at risk so that interventions can be scaled up and targeted
to areas of need.
The global burden and distribution of podoconiosis are not
precisely known: like other neglected tropical diseases (NTDs)
associated with chronic morbidity, the disease is recognised
to be grossly underdetected and underreported due to social,
© The Author(s) 2020. Published by Oxford University Press on behalf of Royal Society of Tropical Medicine and Hygiene. This is an Open Access
article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits
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structural and epidemiological factors.5 Podoconiosis is a highly
stigmatising condition,most prevalent in poor, rural communities
with low access to healthcare for diagnosis and treatment. The
disease is scarcely known among healthcare workers6 and has
been considered ‘the most neglected tropical disease’.7 National
policies and programmes targeting the disease are non-existent
in most of the potentially endemic countries and organisations
working on podoconiosis are limited to a few grassroots non-
governmental organisations. Within this context, people affected
by podoconiosis are unlikely to seek care; if they do, they are
unlikely to be correctly diagnosed or reported.
Given the paucity of routine data on podoconiosis, population-
based surveys combined with environmental modelling have
become the mainstay of ongoing global efforts to estimate the
burden and map the distribution of the disease.8 Surveys in
Cameroon, Ethiopia and Rwanda have found a prevalence of
between 0.06 and 4.05% at the national level, and higher within
barefoot populations.9–11 Predictive models informed by empiri-
cal data from these surveys have revealed strong environmental
associations, with the potential ecological nichemostly restricted
to remote rural areas and characterised by annual precipitation
levels and elevation and a lesser influence of vegetation, topog-
raphy, hydrology and soil factors.12 Extrapolation of this niche
across the African continent suggests that 114.5 million people
in Africa live in areas suitable for the disease.8
The risk of podoconiosis depends also on the level of expo-
sure to irritant soils—people who lack footwear and are engaged
in occupations that involve extensive contact with soil, including
farming, mining, and floor loom weaving, are at highest risk.1 In
Ethiopia, sociodemographic risk factors for podoconiosis include
lack of education, non-professional occupation and living in a
house with mud or earth floors.13 Since these risk factors are
also indicators of general poverty,14 we expect podoconiosis to
be concentrated in deprived populations within environmentally
suitable areas.
There is historical evidence of podoconiosis occurring in
India,2,15–17 although cases are not currently reported by the
health system. The application of an evidence consensus frame-
work, a method designed to evaluate the evidence for the occur-
rence of a disease based on multiple weighted criteria,18,19 iden-
tified strong evidence of podoconiosis occurrence in India.20 The
evidence consensus framework took account of cases reported in
published and grey literature, as well as likely causes of underre-
porting, including the occurrence of diseases with clinically sim-
ilar presentations that might mask the incidence of podoconio-
sis. Despite strong evidence for podoconiosis in India, its current
endemicity status is unknown. The disease may have been elim-
inated through socio-economic development, or it may persist
in suitable environments and populations, unrecognised by the
health system due to underdetection or misdiagnosis.
Lymphoedema is certainly widespread in India,21 which bears
one of the highest burdens of lymphatic filariasis (LF) globally,22,23
with 600 million estimated to be at risk of the disease and
800 000 estimated cases of lymphoedema.24,25 Filarial and geo-
chemical lymphoedema show substantial clinical overlap and are
both associated with acute attacks, which are painful for patients
and cause further lymphatic impairment, leading to worsening
of the condition.26 Podoconiosis surveys in Africa have shown
that podoconiosis is frequently misdiagnosed as LF, the latter
being more widely recognised by healthcare workers.11 This not
only risks underestimation of the burden of podoconiosis, but
may also confound the measurement of progress towards LF
elimination.
From the perspective of casemanagement for lymphoedema,
the distinction of the cause is less important: all patients require
morbiditymanagement and disability prevention (MMDP), includ-
ing frequent washing, elevation and massage, treatment of sec-
ondary infections and management of acute attacks to prevent
further lymphatic impairment.4 In India, training on self-care
is provided through the National Programme to Eliminate Lym-
phatic Filariasis (NPELF), under the National Vector Borne Dis-
ease Control Programme (NVBDCP).25 This implies that hypothet-
ically, podoconiosis cases occurring within LF-endemic districts
may benefit from MMDP if detected through routine channels for
LF morbidity case finding. In contrast, cases of lymphoedema
arising in non-LF-endemic districts are unlikely to receive MMDP
through the NPELF. With this in mind, case finding activities for
podoconiosis would be of most benefit to patients if targeted to
districts not currently providingMMDP services through theNPELF.
In this investigation we aimed to prioritise the selection of
districts for pilot mapping of podoconiosis in India according to
four criteria: potential environmental suitability for podoconio-
sis, higher relative levels of poverty (assuming lower access to
footwear and thus higher exposure to irritant soils among the
poorest), occurrence of lymphoedema cases detected by the
state health authorities and the absence of MMDP services pro-
vided by the LF programme. This is intended to inform a rational
approach to surveying for an unrecognised, geographically focal,
chronic disease in a vast and varied country, with a view to scaling
up to inform a national strategy if required.
Methods
Study design
This was a consensus development exercise, applying a system-
atic framework to consolidate expert opinion and programmatic
experience from within India with empirical evidence from other
countries.
Study location
India is a South Asian country with a population of >1.3 bil-
lion and a total land area of >3 287 263 km2.27 It is organ-
ised into 28 administrative states and 8 union territories,28
further divided into districts, totalling 668 in 2015.29 State gov-
ernments are responsible for the provision of healthcare and the
public health system, while certain specific health programmes
and initiatives are organised by the central government.30,31
LF programme and MMDP for lymphoedema
Government-led programmes to control LF in India have been
implemented for many years, with the current NPELF in place
since 2004.32 Its key strategic pillars are the interruption of
transmission through mass drug administration (MDA) and the
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covered 202 districts in 20 states and union territories and was
subsequently scaled up to reach 256 endemic districts targeting
a population of about 600 million.32 During MDA campaigns,
cases of lymphoedema are recorded at the village or subcen-
tre level through house-to-house visits. Cases are aggregated
at the primary health centre (PHC), district and state levels.
People with lymphoedema are given demonstrations and train-
ing on World Health Organization–recommended hygiene-based
management of lymphoedema and are encouraged to practise
self-care.32
Development of the consensus framework
The consensus framework for the prioritisation of districts for
piloting podoconiosis surveys was developed through a consul-
tative workshop held at the Amrita Institute of Medical Sci-
ences Ernakulam, Kerala, 10-11 December 2019. Experts in pub-
lic health, community medicine, NTDs and LF from all states and
union territories in India (hereafter ‘state representatives’) and
international experts on podoconiosis were invited to this work-
shop in order to share their expertise for development of the
framework. Thosewhowere unable to joinwere engaged through
remote communication after the workshop.
Following presentations on the clinical and epidemiological
aspects of podoconiosis, its treatment, geographic distribution
and environmental associations and LF in India, the group dis-
cussed and refined the framework to consolidate evidence that
would determine priority selection of districts for pilot mapping.
It was agreed that the framework should prioritise districts with
suitable environmental conditions for podoconiosis, where the
population was most at risk based on socio-economic indicators
of poverty, where lymphoedema cases were known to the health
system and where patients were less likely to be served by MMDP
services (Figure 1).
When the final frameworkwas agreed upon, state representa-
tives formed groups to discuss the target criteria in each district
within their states. On the final day of the workshop, state repre-
sentatives presented the results of the consensus framework to
grade the priority for mapping podoconiosis and any data gaps in
each district. Data gaps were later filled through remote consul-
tation with state health officials.
The final criteria for targeting pilot mapping surveys were dis-
trict predicted to be suitable or moderately suitable for podoco-
niosis, district poverty higher than the median, lymphoedema
cases known to the health system within the district and district
does not currently implement MDA against LF and transmission
interruption not recently certified.
Data sources
Environmental suitability for podoconiosis was extrapolated from
an ensemble model using podoconiosis occurrence data from
eight countries in Africa, primarily from national surveys in
Cameroon, Ethiopia and Rwanda,9,10,13 and a suite of envi-
ronmental covariates potentially associated with the disease.
The data sources and development of this model have been
described elsewhere.8 Elevation and annual precipitation were
the strongest predictors within the model, with the highest suit-
ability predicted in areas with 1000– 1500 mm annual precipita-
Environmental suitability quartile
1 = 0 2 = 0 3 = 1 4 = 3
Poverty index
< median = 0 > median = 1
Evidence of lymphedema
Yes = 4 NA = 1 No = 0
Interventions against LF
Yes = 0 NA = 1 No = 4
Suitability of conditions for disease
Potential for incident misdiagnosed cases
Likelihood that misdiagnosed cases receive care
Figure 1. Weighted criteria for prioritisation of districts for pilot mapping
of podoconiosis in India.
tion and elevation >1000 m above sea level. Other environmen-
tal predictors included soil characteristics (clay and silt fractions)
and soil acidity of the topsoil, themean land surface temperature,
distance to the nearest body of water and enhanced vegetation
index, a measure of vegetation cover. The mean suitability was
projected at a resolution of grid cells of 5 km × 5 km and cate-
gorised into quartiles. The modal quartile of averaged suitability
was calculated in each district. Districts with a modal quartile of
4 were classified as ‘suitable’, those with a modal quartile of 3
were classified as ‘moderately suitable’ and those with a modal
quartile <3 were classified as ‘not suitable’.
We used amultidimensional index of poverty (MDPI) produced
by the Oxford Poverty and Human Development Initiative14 to
classify relative levels of poverty at the district level. The MDPI
includes various indicators of health, education and living stan-
dards and takes account of the proportion of the population
who are poor and the intensity of deprivation among the poor.14
The district-level MDPI was assigned to each district defined by
the GADM 2015 based on state and district names, using fuzzy
logic implemented in R (R version 4.0.1 (2020-06-06), R Founda-
tion, Vienna, Austria) to allow for variation in spellings. Districts
with an MDPI above the median value were categorised as ‘more
deprived’.
State representatives compiled surveillance data on the inci-
dence of lymphoedema detected through the health system
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Table 1. Criteria for prioritising pilot mapping of podoconiosis in districts of India
Levels of criterion
Criteria for mapping Number of districts in each category (N=286)
Environmental suitability High (MQ4) Moderate (MQ3) Low (MQ1 and 2)
101 100 85
Relative poverty Higher Lower
124 162
Evidence of lymphoedema Recorded Not recorded Information NA
189 80 17
MMDP services Implemented Not implemented Information NA
15 169 102
Numbers of districts are those described by state representatives. MQ: modal quartile (see Methods)
district was categorised according to the known occurrence of
lymphoedema: ‘present’, ‘not detected’ or ‘unknown’.
The state representatives also contributed programmatic
information on the implementation of interventions against LF
through the NPELF in each district. Districts classified as endemic
or in which interruption of LF transmission had recently been cer-
tifiedwere considered themost likely to deliver MMDP services for
lymphoedema patients.
Data analysis
The units of analysis were districts defined by the state represen-
tatives. Most of these districts were represented in the dataset
of second-level administrative areas in India defined by the
database of Global Administrative Areas (GADM) in 2015,29 while
some were represented in the equivalent version of the dataset
from 201228 but had been redistricted prior to 2015. The districts
described by state representatives were linked to the districts
defined by the GADM 2015 and the GADM 2012 using fuzzy logic,
as described above. Districts that were not represented within
either GADM dataset were manually linked by state representa-
tives to districts from the 2015 shapefile.
The evidence was collated through a scoring system that
attributed fixed scores to different levels of each of the target
criteria (Figure 1). The component scores assigned to each dis-
trictwere summed to provide an overall consensus score. Districts
scoring >75% of the maximum score were considered high pri-
ority for mapping.
In order tomap the results, the evidence compiled in thework-
shop was linked to the shapefile of districts in 2015. Full details
of the linkage of districts to the shapefile are provided in Supple-
mentary Methods.
Results
Representatives from 27 states compiled data for 286 dis-
tricts. The continuous extrapolated environmental suitability for
podoconiosis in India is shown in Supplementary Figure 1. The
modal quartile of averaged suitability was calculated in each dis-
trict and linked to the district cartography. In total, 101 of 286 dis-
tricts described by the state representatives and 191 of 668 from
the GADM 2015 shapefile were predicted to have high suitability
for podoconiosis (Table 1). Moderate suitability was predicted in
100 districts defined by the state representatives and 190 from
the GADM 2015 shapefile. Twenty-three states and union terri-
tories included districts from the GADM 2015 shapefile that were
predicted highly suitable.
Data on the incidence of lymphoedema was obtained for 269
districts within 24 states. The state representatives reported lym-
phoedema cases known to the health system in 189 districts.
Information on MDA implementation was available for 184 dis-
tricts, representing 19 states. These data indicated that 15 dis-
tricts were LF endemic or had recently interrupted transmission,
while 169 had no LF programme coverage and were thus unlikely
to be implementing MMDP services (Table 1).
Figure 2 shows the levels of each component at the dis-
trict level. Supplementary Table 1 shows the full results of the
weighted scoring system for all of the districts identified by the
state representatives. A full summary of the evidence categories
assigned for all observed configurations of component scores is
shown in Supplementary Figure 2. In total, 35 districts were iden-
tified as high priority for mapping and 108 were classified as
medium priority (Table 2, Figure 3).
The districts listed by state representatives that were pre-
dicted highly suitable represented 17 states and union territo-
ries. Districts with higher levels of poverty were in 19 states
and union territories. Lymphoedema cases were known to the
health system in 12 states and union territories and 17 states
and union territories were not known to implement interventions
against LF.
Discussion
Through a cooperative, consultative process, we have devel-
oped and applied an evidence-based framework to prioritise
the selection of districts for podoconiosis case finding sur-
veys in India. The key criteria identified through the consensus
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Not provided through NLFEP
Information NA
DLymphoedema cases
Not known to the health system
Known to the health system
Information NA
C
Figure 2. Component scores for prioritisation of podoconiosis mapping surveys at the district level.
evidence from environmental modelling and socio-economic
indicators, the occurrence of conditions clinically consistent with
the disease according to local expert opinion and the absence of
case management services based on the coverage of the NPELF.
This enabled the identification of 35 districts where the disease
was most likely to occur and where patients were least likely to
be able to access MMDP services. These districts are considered to
be key targets for initial surveys to establish the endemicity status
of podoconiosis in India.
The priority districts we identified are dispersed through nine
states across India. None of the districts were assigned the max-
imum score across all of the criteria, and among those identified
as being high priority mapping targets, there is variability in their
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Table 2. Total numbers of districts by level of priority for mapping




0–24 Very low 9
had known cases of lymphoedema and no known MMDP ser-
vices but were predicted to be only moderately environmentally
suitable and showed lower rates of relative poverty. Other dis-
tricts identified as high priority had high environmental suitabil-
ity, known cases of lymphoedema and no information on MMDP
services. The framework and results are intended to provide an
evidence-based tool to facilitate and informdecisions rather than
to drive them. Other criteria, such as logistical feasibility of sur-
veying, will also be considered when these decisions are made.
A key strength of this exercise was its success in consolidating
a substantive knowledge base from experts of multiple relevant
disciplines acrossmost states of India. The consultativeworkshop
enabled the sharing of knowledge and ideas among a group with
a great diversity of experience and brought a varied range of per-
spectives to the development of the consensus framework. The
outcome was a locally relevant evidence base supported by var-
ied sources of empirical data and expert opinion. The collabora-
tive process also built a supportive and knowledgeable local net-
work that will be vital to the success of future efforts to map and
address the burden of podoconiosis in India, if it is found to be
endemic.
Throughout the consultation, there was ongoing discussion
on the justification for each of the criteria within the framework.
There was recognition of the need to balance rational resource
allocation with sensitivity to detect a disease that might occur
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area. Due to the lack of contemporary data on podoconiosis
in India, suitability for podoconiosis was extrapolated from an
environmental model informed by data from Africa. It is not
known whether the environmental associations of podoconio-
sis in Africa can be applied in India, but since podoconiosis
has strong environmental drivers and is associated with spe-
cific geographic and climatic conditions, the main environmental
associations are expected to be consistent across different geo-
graphical areas. This is supported by experience of podoconiosis
surveys in Cameroon that identified the highest rates of the dis-
ease in areas predicted to be highly suitable by a model based
mainly on data from Ethiopia.9 In this investigation, districts were
classified as highly suitable if most of the area within them
was in the upper quartile of suitability based on environmental
model predictions. This classification may have deprioritised dis-
tricts with varied environmental conditions and focal suitability
for podoconiosis. Prospective pilot surveys in India will provide
an opportunity to evaluate the external validity of the existing
models. Furthermore, any newly identified cases will be used to
develop more specific models of environmental suitability within
India, which will inform the scale-up ofmapping surveys and bur-
den estimation.
The investigationwas affected bymissing data, particularly on
the occurrence of lymphoedema and the provision of MMDP ser-
vices at the district level. The true distribution of lymphoedema
in India, which may include cases of podoconiosis, is likely to be
broader than that represented by existing surveillance data. This
may have led to deprioritisation of potentially endemic districts
lacking data. The coverage of MMDP servicesmay also be broader
than we estimated, since such services may be delivered outside
of the LF elimination programme or at a small local scale. We
do not consider this to be a significant limitation to the work: if
surveys are implemented in districts where MMDP is already pro-
vided, itmay be possible to strengthen and support these services
to ensure they reach all people affected by lymphoedema.
Our results will help determine the contemporary endemicity
of podoconiosis in India, refine global understanding of the epi-
demiology of the disease and guide future mapping strategies.
We recommend a pilot study using robust sampling and diag-
nostic strategies be conducted in one or two districts. The aims
of this study will be to establish the occurrence of podoconiosis
and to investigate its social and spatial epidemiology in India. The
study must be carefully designed to detect spatial and environ-
mental variation, which are critical for futuremodelling of the risk
of podoconiosis across India.
Conclusion
The consensus development framework we have applied consti-
tutes an important first step in building the evidence for podoco-
niosis endemicity in a country where there is a strong indication
of disease existence but scarce data for public health action. As
a preliminary exercise, this analysis suggests that podoconiosis
may occur in multiple districts across India. If true, this implies a
large population at risk, some of whom would not be covered by
existing services for MMDP. Case searches for podoconiosis should
be planned in districts most likely to harbour cases of podoco-
niosis and least likely to provide MMDP to those affected. These
targeted searcheswill help to clarify the epidemiological status of
podoconiosis in India, supporting the global understanding of the
burden of podoconiosis and efforts to ensure access to prevention
and treatment for those at risk of or affected by the disease.
Supplementary data
Supplementary data are available at Transactions online.
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